Other studies have found that vitamin B2 is a promising sensitizer, capable of enhancing the efficacy of vitamin C–based cancer chemoprevention and chemotherapy by inhibiting the phosphorylation of Akt and Bad [53]. The gene discussed is AKT1; the disease is cancer.